1. Home
  2. NBH vs SOPH Comparison

NBH vs SOPH Comparison

Compare NBH & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBH
  • SOPH
  • Stock Information
  • Founded
  • NBH 2002
  • SOPH 2011
  • Country
  • NBH United States
  • SOPH Switzerland
  • Employees
  • NBH N/A
  • SOPH N/A
  • Industry
  • NBH Finance/Investors Services
  • SOPH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NBH Finance
  • SOPH Health Care
  • Exchange
  • NBH Nasdaq
  • SOPH Nasdaq
  • Market Cap
  • NBH 308.6M
  • SOPH 309.2M
  • IPO Year
  • NBH N/A
  • SOPH 2021
  • Fundamental
  • Price
  • NBH $11.03
  • SOPH $4.60
  • Analyst Decision
  • NBH
  • SOPH Strong Buy
  • Analyst Count
  • NBH 0
  • SOPH 3
  • Target Price
  • NBH N/A
  • SOPH $7.33
  • AVG Volume (30 Days)
  • NBH 85.9K
  • SOPH 55.0K
  • Earning Date
  • NBH 01-01-0001
  • SOPH 08-06-2024
  • Dividend Yield
  • NBH 4.34%
  • SOPH N/A
  • EPS Growth
  • NBH N/A
  • SOPH N/A
  • EPS
  • NBH 0.12
  • SOPH N/A
  • Revenue
  • NBH N/A
  • SOPH $64,184,000.00
  • Revenue This Year
  • NBH N/A
  • SOPH $28.97
  • Revenue Next Year
  • NBH N/A
  • SOPH $28.39
  • P/E Ratio
  • NBH $87.04
  • SOPH N/A
  • Revenue Growth
  • NBH N/A
  • SOPH 26.68
  • 52 Week Low
  • NBH $8.75
  • SOPH $2.13
  • 52 Week High
  • NBH $11.01
  • SOPH $7.37
  • Technical
  • Relative Strength Index (RSI)
  • NBH 65.58
  • SOPH 47.44
  • Support Level
  • NBH $10.77
  • SOPH $4.41
  • Resistance Level
  • NBH $11.07
  • SOPH $4.77
  • Average True Range (ATR)
  • NBH 0.11
  • SOPH 0.18
  • MACD
  • NBH -0.00
  • SOPH 0.01
  • Stochastic Oscillator
  • NBH 89.74
  • SOPH 58.52

About NBH Neuberger Berman Municipal Fund Inc.

Neuberger Berman Intermediate Muni Fund is a closed-end management investment company that invests mainly in municipal securities. It aims to provide common stockholders a high level of current income exempt from Federal income tax.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: